| Tipo : |
periódico |
| Enlace : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386 |
|
| Los equipos de investigación : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Autores : |
Friciu M, Zaraa S, Leclair G. |
| Título : |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions |
| número : |
Can J Hosp Pharm ; 69, 4: 327-329. 2016 |
|
| Nivel de evidencia : |
|
| La estabilidad física : |
|
| Estabilidad química : |
|
| otros métodos : |
|
| Comentarios : |
|
Lista de la molécula
 Amlodipine besylate
|
 |
 |
 |
 |
30 mg
Norvasc® |
|
23-27°C |
 |
| 60 |
 |
|
|
|
|
 |
30 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 60 |
|
|
|
|
|
|
30 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
30 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
1 mg
Norvasc® |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
|
